{"schema_version":"secwatch.filing_event.v1","accession":"0001185185-21-001231","form_type":"8-K","ticker":"BHIC","cik":"0001784440","company_name":"BioScience Health Innovations, Inc.","filed_at":"2021-09-01T23:59:59+00:00","discovered_at":"2026-05-14T18:04:19.650867+00:00","generated_at":"2026-06-29T06:33:12.445613+00:00","sec_items":["5.01","5.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Nowtransit Inc. change of control: Justin Earl acquires 51.3% stake, becomes President and sole director","bullets":["Justin Earl purchased 2,800,000 shares (51.3% of common stock) from former majority shareholder Ivan Homici for $28,000 on April 2, 2021.","Ivan Homici resigned as director, President, Treasurer, and Secretary on July 29, 2021; Justin Earl replaced him in all roles.","Justin Earl, age 47, previously served as President of Strategic Junction since 2011, focusing on business continuity and risk management.","No related party transactions or other arrangements existed between the company and Mr. Earl."],"urls":{"canonical":"https://secwatch.observer/filing/0001185185-21-001231","json":"https://secwatch.observer/filing/0001185185-21-001231.json","markdown":"https://secwatch.observer/filing/0001185185-21-001231.md","text":"https://secwatch.observer/filing/0001185185-21-001231.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1784440/000118518521001231/0001185185-21-001231-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1784440/000118518521001231/nowtransit20210901_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T06:33:12.445613+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"06726fb971","claim":"Ivan Homici resigned as President at BioScience Health Innovations, Inc..","evidence_excerpt":"On July 29, 2021, Mr. Homici resigned as the Company’s director, President, Treasurer and Secretary and was replaced in each such role by Mr. Earl.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1784440/000118518521001231/0001185185-21-001231-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"President"}],"fact_type":"executive_change"},{"claim_id":"d80e75c3fa","claim":"Justin Earl was appointed as President at BioScience Health Innovations, Inc..","evidence_excerpt":"On July 29, 2021, Mr. Homici resigned as the Company’s director, President, Treasurer and Secretary and was replaced in each such role by Mr. Earl.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1784440/000118518521001231/0001185185-21-001231-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}